Biochemical Suppliers, Biotechnology Engineers
Quell Therapeutics Limited
Quell Therapeutics Limited is a company based in London, England. They specialize in providing biochemical supplies, biotechnology engineering, materials and chemicals, and IT and e-commerce services. Their headquarters are located at Level 3, Translation & Innovation Hub, 84 Wood Ln, London W12 0BZ, United Kingdom.
Introduction to Quell Therapeutics Limited
Quell Therapeutics Limited is a UK-based biotechnology company that focuses on developing engineered T-regulatory cells for treating autoimmune and inflammatory diseases. The company was founded in 2019 by Syncona, a leading healthcare investment firm, and the University College London (UCL) Business. What makes Quell Therapeutics unique is its expertise in cell engineering, combining biological and computational methods to develop a scalable and consistent manufacturing process for T-regulatory cells.Services & Products
Quell Therapeutics offers advanced cell therapy solutions for patients with autoimmune and inflammatory diseases. The company's flagship product is QTL1901, a CAR-Treg cell therapy for the treatment of graft-versus-host disease (GvHD). Quell Therapeutics also develops other T-regulatory cell therapies for type 1 diabetes, multiple sclerosis, and rheumatoid arthritis.Location
Quell Therapeutics is located in London's White City area, in the Translation & Innovation Hub at Imperial College's White City Campus. The area is known for its vibrant startup scene, with many innovative companies and research institutions in the biotech and life sciences sectors. Customers can expect to find a range of cafes, restaurants, and shops in the area. The nearest public transportation options are Wood Lane station (0.2 miles), White City station (0.4 miles), and Shepherd's Bush station (0.6 miles).Benefits
Customers should choose Quell Therapeutics because of its cutting-edge technology and unique approach to cell engineering. The company's expertise in T-regulatory cell therapy has the potential to transform the treatment of autoimmune and inflammatory diseases. Quell Therapeutics also has strong partnerships with leading research institutions and healthcare organizations, ensuring that its products are safe and effective.Good to know
Customers should be aware that Quell Therapeutics is a relatively new company, founded in 2019. While the company has made significant progress in developing its cell therapy products, they are still in the clinical trial phase and not yet available for commercial use.Reviews
Customer reviews of Quell Therapeutics are not yet available, as the company's products are still in development.Amenities
-
online ordering
-
technical support
-
custom packaging
-
samples
-
delivery tracking
-
quality assurance
-
regulatory compliance
-
laboratory
-
equipment
-
software
-
networking
-
automation
-
robotics
-
data analysis
-
research
-
development
-
design
-
testing
-
maintenance
-
troubleshooting
-
consulting
-
training